↓ Skip to main content

Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2009
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
Published in
Orphanet Journal of Rare Diseases, March 2009
DOI 10.1186/1750-1172-4-10
Pubmed ID
Authors

Pierluigi Carratù, Lucia Spicuzza, Anna Cassano, Mauro Maniscalco, Felice Gadaleta, Donato Lacedonia, Cristina Scoditti, Ester Boniello, Giuseppe Di Maria, Onofrio Resta

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, which rapidly leads to chronic respiratory failure requiring mechanical ventilation. Currently, forced vital capacity (FVC) < 50% is considered as physiologic marker for admitting patients to Noninvasive Positive Pressure Ventilation (NPPV) intervention, although it has been recently shown the median survival of patients with baseline FVC < 75% much shorter than median survival of patients with baseline FVC > 75%, independently by any treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Germany 1 1%
Brazil 1 1%
Unknown 85 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 20%
Student > Master 13 15%
Other 11 13%
Student > Bachelor 9 10%
Student > Ph. D. Student 8 9%
Other 19 22%
Unknown 10 11%
Readers by discipline Count As %
Medicine and Dentistry 50 57%
Agricultural and Biological Sciences 7 8%
Nursing and Health Professions 5 6%
Neuroscience 3 3%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 5 6%
Unknown 16 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2009.
All research outputs
#15,240,835
of 22,660,862 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,775
of 2,590 outputs
Outputs of similar age
#79,589
of 94,094 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#7
of 7 outputs
Altmetric has tracked 22,660,862 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,590 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,094 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.